Serum phosphate levels reflect responses to cardiac resynchronization therapy in chronic heart failure patients
Serum phosphate levels reflect responses to cardiac resynchronization therapy in chronic heart failure patients
复制标题
血清磷酸盐水平反映慢性心力衰竭患者对心脏再同步治疗的反应
DOI:
10.1016/j.joa.2014.06.006
复制
发表时间:
2015
影响因子:
2
通讯作者:
Takeishi Y
中科院分区:
文献类型:
--
作者:
Kamiyama Y;Suzuki H;Yamada S;Kaneshiro T;Takeishi Y
BackgroundRecent studies have shown that high levels of serum phosphate are associated with adverse cardiovascular events. However, little is known about the relation between phosphate levels and improvement of cardiac function in chronic heart failure (CHF) patients who underwent cardiac resynchronization therapy (CRT). The purpose of this study was to examine whether serum phosphate levels were able to predict responders to CRT and adverse cardiac events.MethodsThe study population consisted of 30 CHF patients (24 males, mean age 65.7±8.5 years) who received CRT with defibrillator (CRT-D) implantation. Levels of serum phosphate were measured before, and 6 months after, CRT-D implantation. Left ventricular end-diastolic volume and end-systolic volume were assessed simultaneously by echocardiography. In addition, the rate of re-hospitalization due to worsening of heart failure was investigated. All patients were divided into 2 groups: responders (Group-R,n=18) and non-responders (Group-NR,n=12) to CRT-D. Responders were defined as patients who showed >15% reduction in left ventricular end-systolic volume. We compared these parameters between the 2 groups.ResultsSerum phosphate levels were significantly lower in Group-R than in Group-NR (3.3±0.2 vs. 3.7±0.4 mg/dL,p=0.01). The rate of re-hospitalization was lower in Group-R than in Group-NR (0% vs. 33%,p=0.018). Multivariate analysis showed that serum phosphate levels had a predictive power to determine responders to CRT (odds ratio 0.008, 95% confidence interval 0.000–0.348,p=0.015).ConclusionsThese results suggest that serum phosphate levels might predict both responders to CRT, and adverse cardiac events, in CHF patients with CRT-D.
登录
查看更多内容
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
M. Favus
通讯作者:
M. Favus
影响因子:
37.8
作者:
Anand, Inder S.;Carson, Peter;Bristow, Michael R.
通讯作者:
Bristow, Michael R.
DOI:
10.1016/s0084-3873(08)70120-2
发表时间:
2007
期刊:
Yearbook of Medicine
影响因子:
--
作者:
R. Garrick
通讯作者:
R. Garrick
DOI:
10.1177/1043454220966590
发表时间:
2021
期刊:
Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses
影响因子:
--
作者:
Withycombe,JaniceS;Carlson,Aimee;Coleman,Carly;Leslie,SharonL;Skeens,Micah;Tseitlin,Hanna;Duffy,ElizabethA
通讯作者:
Duffy,ElizabethA
影响因子:
3.7
作者:
Rooney J;Byrne S;Heverin M;Corr B;Elamin M;Staines A;Goldacre B;Hardiman O
通讯作者:
Hardiman O